Search clinical trials for: Olopatadine Hydrochloride 0.2% BAK

Total 487 results

Alcon Research

Completed

Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects

Allergic Conjunctivitis
Alcon Research

Completed

Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects

Allergic Conjunctivitis
Takeda

Active, not recruiting

A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet

Celiac Disease

United States, Belgium, Poland, Italy, Canada, United Kingdom, France, Spain
Laboratorios Poen

Completed

Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis Treatment

Allergic Conjunctivitis

Argentina
Alcon Research

Completed

Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis

Allergic Conjunctivitis
Takeda

Completed

Phase 1/2 Study of TAK-850 Intramuscular Injection in Healthy Pediatric Participants

Influenza Infection

Japan
Alcon Research

Completed

Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis

Allergic Conjunctivitis
Allergan

Completed

A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis

Conjunctivitis, Allergic

United States
Alcon Research

Completed

Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age

Allergic Rhinitis

United States
Aciex Therapeutics, Inc.

Completed

A Comparison of the Safety and Comfort of AC-170

Normal Ocular Health

United States
Alcon Research

Completed

Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis

Perennial Allergic Rhinitis

United States
Andover Research Eye Institute

Completed

A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Allergan

Completed

A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis

Conjunctivitis, Allergic

United States
Bausch & Lomb Incorporated

Completed

Alrex® Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC)

Seasonal Allergic Conjunctivitis

Singapore
Alcon Research

Completed

A Study of Patient Perception and Quality of Life Associated With the Use of Olopatadine 0.2% in Subjects With Allergic Conjunctivitis

Allergic Conjunctivitis

India
Alcon Research

Completed

Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients

Allergic Conjunctivitis

United States
Alcon Research

Completed

An Open-Label, Long-Term Study With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic Conjunctivitis

Allergic Conjunctivitis

Japan
Alcon Research

Completed

Safety and Comfort of AL-4943A Ophthalmic Solution

Allergic Conjunctivitis
Allergan

Completed

Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis

Rhinitis, Allergic, Seasonal | Conjunctivitis, Allergic

India
Alcon Research

Completed

Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis

Allergic Conjunctivitis
Alcon Research

Completed

Assessment of Alcon's Ocular Image Quantification System

Allergic Conjunctivitis

United States
Alcon Research

Completed

Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model

Allergic Conjunctivitis
McCabe Vision Center

Completed

Comparing Patient Satisfaction With Pataday or Bepreve

Eye Allergies

United States
Alcon Research

Completed

Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients

Seasonal Allergic Rhinitis

United States
Alcon Research

Completed

Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients

Allergic Conjunctivitis

Japan
Alcon Research

Completed

Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR)

Allergic Conjunctivitis
Clinical Research Center of Florida
Ocular Therapeutix, Inc.

Completed

DEXTENZA Therapy for Treatment of Allergic Conjunctivitis

Bilateral Conjunctivitis (Disorder)

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Suspended

Copanlisib and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Recurrent Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma

United States
University of Chicago
GlaxoSmithKline

Completed

Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms

Seasonal Allergic Rhinitis

United States
Alcon Research

Completed

Safety Study of Olopatadine Nasal Spray

Perennial Allergic Rhinitis

United States
Cairo University

Completed

Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean

Post Partum Hemorrhage

Egypt
Alcon Research

Completed

Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid

Seasonal Allergic Rhinitis

United States
Laboratoires Thea

Completed

Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis

Seasonal Allergic Conjunctivitis

France
Alcon Research

Completed

Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Santen Pharmaceutical Co., Ltd.

Completed

Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis

Allergic Conjunctivitis

Japan
Senju USA, Inc.

Completed

Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Michael Marchand, MD
Université de Montréal

Recruiting

Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis

Conjunctivitis, Allergic | Conjunctivitis, Vernal

Canada
Alcon Research

Completed

Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis

Allergic Rhinitis

United States
Aerie Pharmaceuticals

Completed

Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Primary Open Angle Glaucoma | Ocular Hypertension

Japan
China Medical University, China

Completed

Preoperative Versus Postoperative Ultrasound-guided Rectus Sheath Block for Sleep Quality and Cytokines of Patients

Postoperative Pain

China
Kasr El Aini Hospital

Unknown

Use of Two Modern Hydroxyethyl Starch Solutions in Major Urological Procedures

Urologic Surgical Procedures

Egypt
Alcon Research

Completed

Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan

Allergic Conjunctivitis
J P Lecoq

Completed

Local Anesthetic Automated Intermittent Administration vs. Continuous Infusion Via Femoral Nerve Block.

Postoperative Complications | Postoperative Pain

Belgium
Laboratorios Sophia S.A de C.V.

Withdrawn

Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic Conjunctivitis

Allergic Conjunctivitis
Betta Pharmaceuticals Co., Ltd.
Tigermed Consulting Co., Ltd

Completed

Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis

Psoriasis

China
University of Wisconsin, Madison
National Eye Institute (NEI)

Completed

Effect of Olopatadine on Allergic Tear Mediators

Allergic Conjunctivitis

United States
Takeda

Withdrawn

A Phase 1, Single and Multiple Dose Study of TAK-137

Healthy Japanese Adult Male

Japan
ALK-Abelló A/S
Merck Sharp & Dohme LLC

Completed

Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)

Rhinitis, Allergic, Perennial | Rhinitis, Allergic, Nonseasonal
Vanderbilt University Medical Center

Completed

Olopatadine Eye Drops and Allergy Skin Testing

Allergic Rhinitis | Allergic Conjunctivitis

United States
University of Alberta

Withdrawn

A Study to Systematically Assess the Efficacy and Safety of Intravenous Albumin Infusions in Severe POTS

Postural Orthostatic Tachycardia Syndrome

3

Subscribe